金吾财讯 | 金斯瑞生物科技(01548)一度涨超5%，截至发稿，涨2.84%，报12.32港元，成交额1.53亿港元。消息面上，金斯瑞生物科技发盈喜，预期截至2024年12月31日止年度的净利润较2023年同期有重大增长。集团预期净利润增长主要来自以下原因：(1) 视作出售传奇生物的一次性未实现收益约32亿美元；(2) 蓬勃生物A类和C类优先股公允价值变动带来公司年度非现金公允价值亏损约1.24亿美元；(3) 从非细胞疗法业务角度，及剔除以上(1)和(2)项影响后，报告期内经调整净利润保持稳定，较上期未发生重大变化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.